Compare VYNE & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYNE | AMST |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 11.8M |
| IPO Year | 2018 | 2020 |
| Metric | VYNE | AMST |
|---|---|---|
| Price | $0.56 | $2.11 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 507.2K |
| Earning Date | 03-05-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $524,000.00 | $193,505.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.29 | ★ 68.56 |
| 52 Week Low | $0.28 | $1.79 |
| 52 Week High | $3.08 | $4.78 |
| Indicator | VYNE | AMST |
|---|---|---|
| Relative Strength Index (RSI) | 59.71 | 48.00 |
| Support Level | $0.56 | $2.01 |
| Resistance Level | $0.58 | $2.15 |
| Average True Range (ATR) | 0.02 | 0.12 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 26.59 | 88.89 |
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.